Neurofeedback for Youth Trauma
Trial Summary
What is the purpose of this trial?
The purpose of this study is to test the feasibility and effectiveness of a neurofeedback intervention conducted as an adjunctive behavioral health treatment to reduce trauma and affective symptoms in trauma-exposed youth.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Neurofeedback Intervention for youth trauma?
Is neurofeedback generally safe for children?
How does the neurofeedback treatment for youth trauma differ from standard care?
Neurofeedback is a unique treatment that uses real-time monitoring of brain activity to help individuals learn to regulate their brain function, which is different from standard care that often involves medication or physical therapies. This approach is novel because it focuses on training the brain directly, rather than using drugs or physical interventions.910111213
Eligibility Criteria
This trial is for children aged 6-12 who have experienced trauma and are receiving or eligible for trauma-focused therapy. They must have a caregiver, speak English, and own a device compatible with the MUSE Calm app. Children at high risk of suicide, experiencing psychosis, or with epilepsy cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive routine clinical psychotherapy plus 3 to 4 neurofeedback interventions per week
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Neurofeedback Intervention
- Standard of Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor